<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="37798" end="37803" sStart="37776" offset="22" sid="r7.1.use.v.0331" wn="1" wnkey="use%2:34:01::" text="ELISAs were developed using ABTS in citrate buffer, 0.03% H2O2." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2172-3-2.anc" start="29783" end="29787" sStart="null" offset="0" sid="null" wn="3" wnkey="time%1:28:00::" text="Aliquots of the enzyme solutions were removed over &lt;b&gt;time&lt;/b&gt;, diluted and assayed for activity using 1 mM suc-AAPF-pNA substrate in 100 mM Tris pH 8.6 containing 0.0005% Tween-80." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2172-3-2.anc" start="29783" end="29787" sStart="null" offset="0" sid="null" wn="3" wnkey="time%1:28:00::" text="Aliquots of the enzyme solutions were removed over &lt;b&gt;time&lt;/b&gt;, diluted and assayed for activity using 1 mM suc-AAPF-pNA substrate in 100 mM Tris pH 8.6 containing 0.0005% Tween-80." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2172-3-2.anc" start="14607" end="14611" sStart="null" offset="0" sid="null" wn="8" wnkey="time%1:28:04::" text="Average titers for four animals per group are &lt;b&gt;shown&lt;/b&gt; in Figure 6. Immunization with the modified enzyme resulted in higher titers of antigen-specific IgG at early &lt;b&gt;time&lt;/b&gt; points in the immunization protocol (Figure 6a)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="13817" end="13823" sStart="null" offset="25" sid="r11.strong.j.0982" wn="1" wnkey="strong%3:00:00::" text="Therefore, creation of a strong T cell epitope in this protein initiates an immune response that leads to the diversification of T cell responses to other regions of the molecule." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="20718" end="20724" sStart="null" offset="113" sid="r11.strong.j.0052" wn="1" wnkey="strong%3:00:00::" text="We have shown that a single conservative amino acid change in a bacterial subtilisin enzyme can create a strong T cell epitope in our guinea pig model." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="20718" end="20724" sStart="null" offset="113" sid="r11.strong.j.0052" wn="2147483644" wnkey="null" text="We have shown that a single conservative amino acid change in a bacterial subtilisin enzyme can create a strong T cell epitope in our guinea pig model." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="36404" end="36414" sStart="null" offset="97" sid="r10.particular.j.0335" wn="2" wnkey="particular%5:00:02:specific:00" text="A proliferative response was counted as positive if the average counts for a particular peptide were three times higher than the control levels." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="26365" end="26375" sStart="null" offset="488" sid="r10.particular.j.0238" wn="3" wnkey="particular%5:00:00:uncommon:00" text="Changing the interaction of peptide, MHC class II molecules, T cell receptors and other antigen-presenting cell specific ligand interactions to foster stronger, higher affinity T cell signalling has been shown in mice to skew T cell differentiation from Th2 to Th1-like patterns [ 40 41 42 43 44 45 46 47 48 49 50 ] . Differences in Th-differentiation patterns have downstream effects on the type of immune response mounted, and in particular on the isotypes of antibody expressed." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="23471" end="23477" sStart="null" offset="79" sid="r8.number.n.0191" wn="1" wnkey="number%1:07:00::" text="The use of a T cell epitope-modified whole protein immunogen confers a number of advantages." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="19613" end="19619" sStart="null" offset="133" sid="r9.level.n.0261" wn="1" wnkey="level%1:07:00::" text="In addition, a single immunization with the T cell epitope modified variant GP002 is sufficient to induce higher levels of parent-enzyme-specific IgG after subsequent immunizations with the unmodified parent enzyme." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="43" end="47" sStart="null" offset="0" sid="r10.high.j.0922" wn="1" wnkey="high%3:00:02::" text="High affinity humoral immune responses to most protein antigens require cognate interactions between antigen-specific T and B cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="19289" end="19293" sStart="null" offset="97" sid="r9.fold.v.0087" wn="2147483646" wnkey="null" text="Results clearly show once again that immunization with GP002 induces over 10-fold higher levels of antigen-specific IgG than the unmodified parent enzyme (Figure 8)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="19289" end="19293" sStart="null" offset="97" sid="r9.fold.v.0087" wn="2147483646" wnkey="null" text="Results clearly show once again that immunization with GP002 induces over 10-fold higher levels of antigen-specific IgG than the unmodified parent enzyme (Figure 8)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="7787" end="7791" sStart="null" offset="181" sid="r9.fold.v.0968" wn="2147483645" wnkey="null" text="At the 6 to 10 week time points, titers leveled off and the average titers induced by immunizations with B. lentus subtilisin were about 10 fold higher than BPN' Y217L." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="19289" end="19293" sStart="null" offset="97" sid="r9.fold.v.0087" wn="2147483645" wnkey="null" text="Results clearly show once again that immunization with GP002 induces over 10-fold higher levels of antigen-specific IgG than the unmodified parent enzyme (Figure 8)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="19289" end="19293" sStart="null" offset="97" sid="r9.fold.v.0087" wn="" wnkey="null" text="Results clearly show once again that immunization with GP002 induces over 10-fold higher levels of antigen-specific IgG than the unmodified parent enzyme (Figure 8)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="25144" end="25149" sStart="null" offset="16" sid="r10.find.v.0913" wn="4" wnkey="find%2:32:00::" text="In addition, we found that the creation of a T cell epitope in BPN' Y217L resulted in a complex pattern of T cell response to the enzyme." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="34231" end="34236" sStart="null" offset="12" sid="r10.find.v.0698" wn="4" wnkey="find%2:32:00::" text="Titers were found by using a log-based slope equation where the O.D." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-2.anc" start="37585" end="37590" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="The secondary antibody, anti-guinea pig IgG-HRPO) (Jackson ImmunoResearch, West Grove, PA) was diluted 1:1000 in 1%BSA/PBS and 100 ?l of dilute conjugate was &lt;b&gt;added&lt;/b&gt; to each well." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="22304" end="22311" sStart="null" offset="92" sid="r11.absence.n.0160" wn="1" wnkey="absence%1:26:00::" text="It was of interest that the unmodified protease induces antigen-specific IgG in the absence of detectable immunodominant T cell epitopes." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-2.anc" start="36066" end="36073" sStart="null" offset="54" sid="r11.absence.n.0216" wn="1" wnkey="absence%1:26:00::" text="Control cultures contained 0.5% DMSO in the absence of peptide." />
  </sentences>
</list>